Quinolones News

#1 April 27, 2012

A new Russian study shows that a combination of levofloxacin and rezonizate is effective in a murine model of Mycobacterium tuberculosis

Rezonizate is a new antituberculosis drug and its efficacy in combination with fluoroquinolones was tested in a murine model of TB.
Pathomorphological and microbiological testing showed that the greatest therapeutic effect was obtained when rezonizate was used in combination with levofloxacin while the weakest therapeutic effect was obtained when rezonizate was used in combination with gatifloxacin.

PMID: 22359865

Antibiot Khimioter. 2011;56(7-8):22-6.

Source : http://www.ncbi.nlm.nih.gov/pubmed/22359865?dopt=Abstract

 
Return to Quinolones News Index


.

  ©1998-2014 BIOMEDIS International, Ltd. All rights reserved. Reproduction in any manner in whole or part prohibited.
Disclaimer